特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
922748

消化性潰瘍治療薬の世界市場 - 米国・EU・中国:2019年~2025年

Global (United States, European Union and China) Peptic Ulcer Drugs Market Research Report 2019-2025

出版日: | 発行: QYResearch | ページ情報: 英文 105 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
消化性潰瘍治療薬の世界市場 - 米国・EU・中国:2019年~2025年
出版日: 2020年01月20日
発行: QYResearch
ページ情報: 英文 105 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の消化性潰瘍治療薬市場について調査分析し、市場規模、売上、収益、市場シェア、成長率、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 世界の成長動向

  • 世界の消化性潰瘍治療薬市場規模
  • 消化性潰瘍治療薬の成長率:地域別
  • 産業動向

第3章 市場シェア:メーカー別

  • 消化性潰瘍治療薬の売上:メーカー別
  • 収益:メーカー別
  • 消化性潰瘍治療薬の価格:メーカー別
  • 主要メーカーの消化性潰瘍治療薬工場/工場分布・提供エリア
  • 主要メーカーの消化性潰瘍治療薬市場の参入日
  • 主要メーカーの消化性潰瘍治療薬提供製品
  • M&A、拡張計画

第4章 市場規模:種類別

  • 各タイプの売上・収益
  • 世界の消化性潰瘍治療薬の売上市場シェア:種類別
  • 世界の消化性潰瘍治療薬の収益市場シェア:種類別
  • 消化性潰瘍治療薬の価格:種類別

第5章 市場規模:用途別

  • 概要
  • 世界の消化性潰瘍治療薬の売上:用途別

第6章 米国

  • 米国の消化性潰瘍治療薬の内訳データ:企業別
  • 米国の消化性潰瘍治療薬の内訳データ:種類別
  • 米国の消化性潰瘍治療薬の内訳データ:用途別

第7章 EU

  • EUの消化性潰瘍治療薬の内訳データ:企業別
  • EUの消化性潰瘍治療薬の内訳データ:種類別
  • EUの消化性潰瘍治療薬の内訳データ:用途別

第8章 中国

  • 中国の消化性潰瘍治療薬の内訳データ:企業別
  • 中国の消化性潰瘍治療薬の内訳データ:種類別
  • 中国の消化性潰瘍治療薬の内訳データ:用途別

第9章 その他の世界の地域

  • その他の世界の地域の消化性潰瘍治療薬の内訳データ:企業別
  • その他の世界の地域の消化性潰瘍治療薬の内訳データ:種類別
  • その他の世界の地域の消化性潰瘍治療薬の内訳データ:用途別
  • その他の世界の地域の消化性潰瘍治療薬の内訳データ:国別

第10章 企業プロファイル

  • 武田薬品工業
  • ASTRAZENECA
  • PFIZER
  • TEVA PHARMACEUTICALS
  • EA PHARMA
  • ASK PHARM
  • LUOXIN PHARMACEUTICAL
  • ABBOTT LABORATORIES
  • YUHAN
  • DAEWOONG PHARMACEUTICAL

第11章 バリューチェーン分析と販売チャネル分析

  • バリューチェーン分析
  • 販売チャネル分析
  • 消化性潰瘍治療薬の顧客

第12章 市場予測

  • 世界の消化性潰瘍治療薬の売上・収益予測
  • 世界の消化性潰瘍治療薬の売上予測:種類別
  • 世界の消化性潰瘍治療薬の売上予測:用途別
  • 消化性潰瘍治療薬の予測:地域別
  • 米国の市場予測
  • EUの市場予測
  • 中国の市場予測
  • その他の世界の地域

第13章 調査結果と結論

第14章 付録

図表

List of Tables and Figures

  • Table 1. Major Manufacturers Peptic Ulcer Drugs Covered in This Report in 2018
  • Table 2. Global Peptic Ulcer Drugs Market Size Growth Rate by Type (2014-2025) (M Unit)
  • Table 3. Global Peptic Ulcer Drugs Market Share by Application (2014-2025) (M Unit)
  • Table 4. Global Peptic Ulcer Drugs Market Size by Regions 2019-2015 (M USD)
  • Table 5. Global Peptic Ulcer Drugs Sales by Regions 2014-2019 (M Unit)
  • Table 6. Global Peptic Ulcer Drugs Sales Market Share by Regions 2014-2019
  • Table 7. Global Peptic Ulcer Drugs Revenue by Regions 2014-2019 (M USD)
  • Table 8. Global Peptic Ulcer Drugs Revenue Market Share by Regions 2014-2019
  • Table 9. Market Top Trends
  • Table 10. Key Opportunities and Drivers: Impact Analysis (2019-2025)
  • Table 11. Global Peptic Ulcer Drugs Sales by Manufacturers (2018-2019) (M Unit)
  • Table 12. Global Peptic Ulcer Drugs Sales Share by Manufacturers (2018-2019)
  • Table 13. Peptic Ulcer Drugs Revenue by Manufacturers (2018-2019) (M USD)
  • Table 14. Peptic Ulcer Drugs Revenue Share by Manufacturers (2018-2019)
  • Table 15. Global Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 16. Key Manufacturers Peptic Ulcer Drugs Price (2018-2019) (USD/K Unit)
  • Table 17. Key Manufacturers Peptic Ulcer Drugs Plants/Factories Distribution
  • Table 18. Key Manufacturers Peptic Ulcer Drugs Area Served
  • Table 19. Date of Key Manufacturers Enter into Peptic Ulcer Drugs Market
  • Table 20. Key Manufacturers Peptic Ulcer Drugs Product Type
  • Table 21. Global Proton Pump Inhibitors Sales and Revenue (2014-2019) (M Unit) & (M USD)
  • Table 22. Global Antacids Sales and Revenue (2014-2019) (M Unit) & (M USD)
  • Table 23. Global Peptic Ulcer Drugs Sales by Type (2014-2019) (M Unit)
  • Table 24. Global Peptic Ulcer Drugs Sales Share by Type (2014-2019)
  • Table 25. Global Peptic Ulcer Drugs Revenue by Type (2014-2019) (M USD)
  • Table 26. Global Peptic Ulcer Drugs Revenue Share by Type (2014-2019)
  • Table 27. Peptic Ulcer Drugs Price by P-CABs (2014-2019 (USD/K Unit)
  • Table 28. Global Peptic Ulcer Drugs Sales by Application (2014-2019) (M Unit)
  • Table 29. United States Peptic Ulcer Drugs Sales by Company (2018-2019) (M Unit)
  • Table 30. United States Peptic Ulcer Drugs Sales Market Share by Company (2018-2019)
  • Table 31. United States Peptic Ulcer Drugs Sales by Type (2014-2019) (M Unit)
  • Table 32. United States Peptic Ulcer Drugs Sales Market Share by Type (2014-2019)
  • Table 33. United States Peptic Ulcer Drugs Sales by Application (2014-2019) (M Unit)
  • Table 34. United States Peptic Ulcer Drugs Sales Market Share by Application (2014-2019)
  • Table 35. European Union Peptic Ulcer Drugs Sales by Company (2018-2019) (M Unit)
  • Table 36. European Union Peptic Ulcer Drugs Sales Market Share by Company (2018-2019)
  • Table 37. European Union Peptic Ulcer Drugs Sales by Type (2014-2019) (M Unit)
  • Table 38. European Union Peptic Ulcer Drugs Sales Market Share by Type (2014-2019)
  • Table 39. European Union Peptic Ulcer Drugs Sales by Application (2014-2019) (M Unit)
  • Table 40. European Union Peptic Ulcer Drugs Sales Market Share by Application (2014-2019)
  • Table 41. China Peptic Ulcer Drugs Sales by Company (2018-2019) (M Unit)
  • Table 42. China Peptic Ulcer Drugs Sales Market Share by Company (2018-2019)
  • Table 43. China Peptic Ulcer Drugs Sales by Type (2014-2019) (M Unit)
  • Table 44. China Peptic Ulcer Drugs Sales Market Share by Type (2014-2019)
  • Table 45. China Peptic Ulcer Drugs Sales by Application (2014-2019) (M Unit)
  • Table 46. China Peptic Ulcer Drugs Sales Market Share by Application (2014-2019)
  • Table 47. Rest of World Peptic Ulcer Drugs Sales by Company (2018-2019) (M Unit)
  • Table 48. Rest of World Peptic Ulcer Drugs Sales Market Share by Company (2018-2019)
  • Table 49. Rest of World Peptic Ulcer Drugs Sales by Type (2014-2019) (M Unit)
  • Table 50. Rest of World Peptic Ulcer Drugs Sales Market Share by Type (2014-2019)
  • Table 51. Rest of World Peptic Ulcer Drugs Sales by Application (2014-2019) (M Unit)
  • Table 52. Rest of World Peptic Ulcer Drugs Sales Market Share by Application (2014-2019)
  • Table 53. Takeda Pharmaceutical Company Details
  • Table 54. Takeda Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 55. Takeda Pharmaceutical Peptic Ulcer Drugs Product
  • Table 56. AstraZeneca Company Details
  • Table 57. AstraZeneca Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 58. AstraZeneca Peptic Ulcer Drugs Product
  • Table 59. Pfizer Company Details
  • Table 60. Pfizer Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 61. Pfizer Peptic Ulcer Drugs Product
  • Table 62. Teva Pharmaceuticals Company Details
  • Table 63. Teva Pharmaceuticals Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 64. Teva Pharmaceuticals Peptic Ulcer Drugs Product
  • Table 65. EA Pharma Company Details
  • Table 66. EA Pharma Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 67. EA Pharma Peptic Ulcer Drugs Product
  • Table 68. ASK Pharm Company Details
  • Table 69. ASK Pharm Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 70. ASK Pharm Peptic Ulcer Drugs Product
  • Table 71. Luoxin Pharmaceutical Company Details
  • Table 72. Luoxin Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 73. Luoxin Pharmaceutical Peptic Ulcer Drugs Product
  • Table 74. Abbott Laboratories Company Details
  • Table 75. Abbott Laboratories Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 76. Abbott Laboratories Peptic Ulcer Drugs Product
  • Table 77. Yuhan Company Details
  • Table 78. Yuhan Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 79. Yuhan Peptic Ulcer Drugs Product
  • Table 80. Daewoong Pharmaceutical Company Details
  • Table 81. Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2018-2019)
  • Table 82. Daewoong Pharmaceutical Peptic Ulcer Drugs Product
  • Table 83. Peptic Ulcer Drugs Distributors List
  • Table 84. Peptic Ulcer Drugs Customers List
  • Table 85. Global Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit) & (M USD)
  • Table 86. Global Peptic Ulcer Drugs Sales Forecast by Type (2019-2025) (M Unit)
  • Table 87. Global Peptic Ulcer Drugs Sales Forecast by Application (2019-2025) (M Unit)
  • Table 88. Global Peptic Ulcer Drugs Sales Forecast by Regions 2019-2025 (M Unit)
  • Table 89. Global Peptic Ulcer Drugs Revenue Forecast by Regions 2019-2025 (M USD)
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources
  • Figure 1. Peptic Ulcer Drugs Product Picture
  • Figure 2. Global Peptic Ulcer Drugs Market Share by Type in 2018
  • Figure 3. Global Peptic Ulcer Drugs Market Share by Application in 2018
  • Figure 4. Drugstore Use Case
  • Figure 5. Peptic Ulcer Drugs Report Years Considered
  • Figure 6. Global Peptic Ulcer Drugs Market Size 2014-2025 (M USD)
  • Figure 7. Global Peptic Ulcer Drugs Sales 2014-2019 (M Unit)
  • Figure 8. Global Peptic Ulcer Drugs Growth Rate of Key Regions 2019-2025 (M USD)
  • Figure 9. Global Peptic Ulcer Drugs Sales Market Share by Regions 2014-2019
  • Figure 10. Global Peptic Ulcer Drugs Sales Market Share by Regions in 2018
  • Figure 11. Global Peptic Ulcer Drugs Revenue Market Share by Regions 2014-2019
  • Figure 12. Global Peptic Ulcer Drugs Revenue Market Share by Regions in 2018
  • Figure 13. Porter's Five Forces Analysis
  • Figure 14. Global Peptic Ulcer Drugs Sales Share by Manufacturers in 2018
  • Figure 15. Peptic Ulcer Drugs Value Share by Manufacturers in 2018
  • Figure 16. Global Peptic Ulcer Drugs Sales Market Share by Type (2014-2019)
  • Figure 17. Global Peptic Ulcer Drugs Sales Market Share by Type in 2018
  • Figure 18. Global Peptic Ulcer Drugs Revenue Market Share by Type (2014-2019)
  • Figure 19. Global Peptic Ulcer Drugs Revenue Market Share by Type in 2018
  • Figure 20. Global Sales Peptic Ulcer Drugs Market Share by Application (2014-2019)
  • Figure 21. Global Sales Peptic Ulcer Drugs Market Share by Application in 2018
  • Figure 22. United States Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (M Unit)
  • Figure 23. United States Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (M USD)
  • Figure 24. United States Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Figure 25. United States Peptic Ulcer Drugs Market Share by Type in 2018
  • Figure 26. United States Peptic Ulcer Drugs Market Share by Application in 2018
  • Figure 27. European Union Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (M Unit)
  • Figure 28. European Union Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (M USD)
  • Figure 29. European Union Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Figure 30. European Union Peptic Ulcer Drugs Market Share by Type in 2018
  • Figure 31. European Union Peptic Ulcer Drugs Market Share by Application in 2018
  • Figure 32. China Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (M Unit)
  • Figure 33. China Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (M USD)
  • Figure 34. China Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Figure 35. China Peptic Ulcer Drugs Market Share by Type in 2018
  • Figure 36. China Peptic Ulcer Drugs Market Share by Application in 2018
  • Figure 37. Rest of World Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Figure 38. Rest of World Peptic Ulcer Drugs Market Share by Type in 2018
  • Figure 39. Rest of World Peptic Ulcer Drugs Market Share by Application in 2018
  • Figure 40. Japan Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (M Unit)
  • Figure 41. Japan Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (M Unit)
  • Figure 42. Korea Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (M Unit)
  • Figure 43. Korea Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (M Unit)
  • Figure 44. Australia Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (M Unit)
  • Figure 45. Australia Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (M Unit)
  • Figure 46. Taiwan Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (M Unit)
  • Figure 47. Taiwan Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (M Unit)
  • Figure 48. Peptic Ulcer Drugs Value Chain
  • Figure 49. Channels of Distribution
  • Figure 50. Distributors Profiles
  • Figure 51. Global Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 52. Global Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 53. Global Peptic Ulcer Drugs Sales Market Share Forecast by Type (2019-2025)
  • Figure 54. Global Peptic Ulcer Drugs Sales Market Share Forecast by Application (2019-2025)
  • Figure 55. Global Peptic Ulcer Drugs Sales Market Share Forecast by Regions 2019-2025
  • Figure 56. Global Peptic Ulcer Drugs Revenue Market Share Forecast by Regions 2019-2025
  • Figure 57. United States Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 58. United States Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 59. European Union Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 60. European Union Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 61. China Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 62. China Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 63. Japan Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 64. Japan Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 65. Korea Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 66. Korea Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 67. Australia Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 68. Australia Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 69. Taiwan Peptic Ulcer Drugs Sales Forecast 2019-2025 (M Unit)
  • Figure 70. Taiwan Peptic Ulcer Drugs Revenue Forecast 2019-2025 (M USD)
  • Figure 71. Bottom-up and Top-down Approaches for This Report
  • Figure 72. Data Triangulation
  • Figure 73. Key Executives Interviewed
目次

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Peptic Ulcer Drugs.

This report studies the global market size of Peptic Ulcer Drugs especially focuses on key regions like United States, European Union, China, and other regions (Japan, Korea, Australia, and Taiwan).

This study presents the Peptic Ulcer Drugs sales volume, revenue, market share, and growth rate for each key company, and covers the breakdown data (sales, revenue, and market share) by regions, types, and applications. History breakdown data from 2014 to 2019 and forecast to 2025.

For top companies in United States, European Union, and China, this report investigates and analyses the sales, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

By Company:

  • Takeda Pharmaceutical
  • AstraZeneca
  • Pfizer
  • Teva Pharmaceuticals
  • EA Pharma
  • ASK Pharm
  • Luoxin Pharmaceutical
  • Abbott Laboratories
  • Yuhan Pharmaceutical
  • Daewoong Pharmaceutical

By Type:

  • Proton Pump Inhibitors
  • Antacids
  • H2-Antagonists
  • Others

By Application:

  • Hospital and Clinic
  • Clinic

By Region:

  • United States
  • China
  • European Union
  • Japan
  • Korea
  • Australia
  • Taiwan

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 RESEARCH SCOPE
  • 1.2 MAJOR MANUFACTURERS COVERED IN THIS REPORT
  • 1.3 MARKET SEGMENT BY TYPE
    • 1.3.1 Global Peptic Ulcer Drugs Market Size Growth Rate by Type
    • 1.3.2 Proton Pump Inhibitors
    • 1.3.3 P-CABs
    • 1.3.4 Antacids
    • 1.3.5 H2-Antagonists
    • 1.3.6 Ulcer Protective Drugs
  • 1.4 MARKET SEGMENT BY APPLICATION
    • 1.4.1 Global Peptic Ulcer Drugs Market Share by Application (2014-2025)
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Drugstore
  • 1.5 STUDY OBJECTIVES
  • 1.6 YEARS CONSIDERED

2 GLOBAL GROWTH TRENDS

  • 2.1 GLOBAL PEPTIC ULCER DRUGS MARKET SIZE
    • 2.1.1 Global Peptic Ulcer Drugs Revenue 2014-2025
    • 2.1.2 Global Peptic Ulcer Drugs Sales 2014-2025
  • 2.2 PEPTIC ULCER DRUGS GROWTH RATE BY REGIONS
    • 2.2.1 Global Peptic Ulcer Drugs Sales by Regions 2014-2019
    • 2.2.2 Global Peptic Ulcer Drugs Revenue by Regions 2014-2019
  • 2.3 INDUSTRY TRENDS
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter's Five Forces Analysis

3 MARKET SHARE BY MANUFACTURERS

  • 3.1 PEPTIC ULCER DRUGS SALES BY MANUFACTURERS
    • 3.1.1 Peptic Ulcer Drugs Sales by Manufacturers 2018-2019
    • 3.1.2 Peptic Ulcer Drugs Sales Market Share by Manufacturers 2018-2019
  • 3.2 REVENUE BY MANUFACTURERS
    • 3.2.1 Peptic Ulcer Drugs Revenue by Manufacturers (2018-2019)
    • 3.2.2 Peptic Ulcer Drugs Revenue Share by Manufacturers (2018-2019)
    • 3.2.3 Global Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3 PEPTIC ULCER DRUGS PRICE BY MANUFACTURERS
  • 3.4 KEY MANUFACTURERS PEPTIC ULCER DRUGS PLANTS/FACTORIES DISTRIBUTION AND AREA SERVED
  • 3.5 DATE OF KEY MANUFACTURERS ENTER INTO PEPTIC ULCER DRUGS MARKET
  • 3.6 KEY MANUFACTURERS PEPTIC ULCER DRUGS PRODUCT OFFERED
  • 3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS

4 MARKET SIZE BY TYPE

  • 4.1 SALES AND REVENUE FOR EACH TYPE
    • 4.1.1 Proton Pump Inhibitors Sales and Revenue (2014-2019)
    • 4.1.2 Antacids Sales and Revenue (2014-2019)
  • 4.2 GLOBAL PEPTIC ULCER DRUGS SALES MARKET SHARE BY TYPE
  • 4.3 GLOBAL PEPTIC ULCER DRUGS REVENUE MARKET SHARE BY TYPE
  • 4.4 PEPTIC ULCER DRUGS PRICE BY TYPE

5 MARKET SIZE BY APPLICATION

  • 5.1 OVERVIEW
  • 5.2 GLOBAL PEPTIC ULCER DRUGS SALES BY APPLICATION

6 UNITED STATES

  • 6.1 UNITED STATES PEPTIC ULCER DRUGS BREAKDOWN DATA BY COMPANY
  • 6.2 UNITED STATES PEPTIC ULCER DRUGS BREAKDOWN DATA BY TYPE
  • 6.3 UNITED STATES PEPTIC ULCER DRUGS BREAKDOWN DATA BY APPLICATION

7 EUROPEAN UNION

  • 7.1 EUROPEAN UNION PEPTIC ULCER DRUGS BREAKDOWN DATA BY COMPANY
  • 7.2 EUROPEAN UNION PEPTIC ULCER DRUGS BREAKDOWN DATA BY TYPE
  • 7.3 EUROPEAN UNION PEPTIC ULCER DRUGS BREAKDOWN DATA BY APPLICATION

8 CHINA

  • 8.1 CHINA PEPTIC ULCER DRUGS BREAKDOWN DATA BY COMPANY
  • 8.2 CHINA PEPTIC ULCER DRUGS BREAKDOWN DATA BY TYPE
  • 8.3 CHINA PEPTIC ULCER DRUGS BREAKDOWN DATA BY APPLICATION

9 REST OF WORLD

  • 9.1 REST OF WORLD PEPTIC ULCER DRUGS BREAKDOWN DATA BY COMPANY
  • 9.2 REST OF WORLD PEPTIC ULCER DRUGS BREAKDOWN DATA BY TYPE
  • 9.3 REST OF WORLD PEPTIC ULCER DRUGS BREAKDOWN DATA BY APPLICATION
  • 9.4 REST OF WORLD PEPTIC ULCER DRUGS BREAKDOWN DATA BY COUNTRIES
    • 9.4.1 Japan
    • 9.4.2 Korea
    • 9.4.3 Australia
    • 9.4.4 Taiwan

10 COMPANY PROFILES

  • 10.1 TAKEDA PHARMACEUTICAL
    • 10.1.1 Takeda Pharmaceutical Company Details
    • 10.1.2 Takeda Pharmaceutical Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Product Introduction
  • 10.2 ASTRAZENECA
    • 10.2.1 AstraZeneca Company Details
    • 10.2.2 AstraZeneca Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.2.3 AstraZeneca Peptic Ulcer Drugs Product Introduction
  • 10.3 PFIZER
    • 10.3.1 Pfizer Company Details
    • 10.3.2 Pfizer Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.3.3 Pfizer Peptic Ulcer Drugs Product Introduction
  • 10.4 TEVA PHARMACEUTICALS
    • 10.4.1 Teva Pharmaceuticals Company Details
    • 10.4.2 Teva Pharmaceuticals Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Product Introduction
  • 10.5 EA PHARMA
    • 10.5.1 EA Pharma Company Details
    • 10.5.2 EA Pharma Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.5.3 EA Pharma Peptic Ulcer Drugs Product Introduction
  • 10.6 ASK PHARM
    • 10.6.1 ASK Pharm Company Details
    • 10.6.2 ASK Pharm Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.6.3 ASK Pharm Peptic Ulcer Drugs Product Introduction
  • 10.7 LUOXIN PHARMACEUTICAL
    • 10.7.1 Luoxin Pharmaceutical Company Details
    • 10.7.2 Luoxin Pharmaceutical Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.7.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Product Introduction
  • 10.8 ABBOTT LABORATORIES
    • 10.8.1 Abbott Laboratories Company Details
    • 10.8.2 Abbott Laboratories Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.8.3 Abbott Laboratories Peptic Ulcer Drugs Product Introduction
  • 10.9 YUHAN
    • 10.9.1 Yuhan Company Details
    • 10.9.2 Yuhan Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.9.3 Yuhan Peptic Ulcer Drugs Product Introduction
  • 10.10 DAEWOONG PHARMACEUTICAL
    • 10.10.1 Daewoong Pharmaceutical Company Details
    • 10.10.2 Daewoong Pharmaceutical Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 10.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Product Introduction

11 VALUE CHAIN AND SALES CHANNELS ANALYSIS

  • 11.1 VALUE CHAIN ANALYSIS
  • 11.2 SALES CHANNELS ANALYSIS
    • 11.2.1 Peptic Ulcer Drugs Sales Channels
    • 11.2.2 Peptic Ulcer Drugs Distributors
  • 11.3 PEPTIC ULCER DRUGS CUSTOMERS

12 MARKET FORECAST

  • 12.1 GLOBAL PEPTIC ULCER DRUGS SALES AND REVENUE FORECAST 2019-2025
  • 12.2 GLOBAL PEPTIC ULCER DRUGS SALES FORECAST BY TYPE
  • 12.3 GLOBAL PEPTIC ULCER DRUGS SALES FORECAST BY APPLICATION
  • 12.4 PEPTIC ULCER DRUGS FORECAST BY REGIONS
    • 12.4.1 Global Peptic Ulcer Drugs Sales Forecast by Regions 2019-2025
    • 12.4.2 Global Peptic Ulcer Drugs Revenue Forecast by Regions2019-2025
  • 12.5 UNITED STATES MARKET FORECAST
  • 12.6 EUROPEAN UNION MARKET FORECAST
  • 12.7 CHINA MARKET FORECAST
  • 12.8 REST OF WORLD
    • 12.8.1 Japan
    • 12.8.2 Korea
    • 12.8.3 Australia
    • 12.8.4 Taiwan

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

  • 14.1 RESEARCH METHODOLOGY
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 AUTHOR DETAILS
  • 14.3 DISCLAIMER
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.